COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 70 filers reported holding COGENT BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,700,006 | -17.7% | 3,558,975 | 0.0% | 4.18% | -29.7% |
| Q2 2023 | $42,138,264 | +41.5% | 3,558,975 | +29.0% | 5.94% | +16.0% |
| Q1 2023 | $29,769,340 | -6.7% | 2,758,975 | 0.0% | 5.12% | +1.2% |
| Q4 2022 | $31,893,751 | -22.5% | 2,758,975 | 0.0% | 5.06% | -30.1% |
| Q3 2022 | $41,164,000 | +65.4% | 2,758,975 | 0.0% | 7.24% | +27.0% |
| Q2 2022 | $24,886,000 | +113.1% | 2,758,975 | +77.0% | 5.70% | +106.3% |
| Q1 2022 | $11,677,000 | -12.7% | 1,558,975 | 0.0% | 2.76% | -37.4% |
| Q4 2021 | $13,376,000 | +2.0% | 1,558,975 | 0.0% | 4.41% | -7.5% |
| Q3 2021 | $13,111,000 | +3.7% | 1,558,975 | 0.0% | 4.77% | -8.3% |
| Q2 2021 | $12,643,000 | -7.6% | 1,558,975 | 0.0% | 5.20% | -9.9% |
| Q1 2021 | $13,688,000 | -21.8% | 1,558,975 | 0.0% | 5.77% | -7.8% |
| Q4 2020 | $17,507,000 | – | 1,558,975 | – | 6.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 4,038,117 | $46,680,633 | 7.86% |
| COMMODORE CAPITAL LP | 4,319,940 | $49,939 | 7.53% |
| TCG Crossover Management, LLC | 3,631,042 | $41,974,846 | 7.41% |
| Fairmount Funds Management LLC | 2,758,975 | $31,893,751 | 5.06% |
| New Leaf Venture Partners, L.L.C. | 501,530 | $5,797,687 | 4.20% |
| Ghost Tree Capital, LLC | 800,000 | $9,248,000 | 3.95% |
| Vivo Capital, LLC | 1,994,941 | $23,062 | 2.66% |
| 5AM Venture Management, LLC | 790,440 | $9,137,486 | 2.46% |
| Frazier Life Sciences Management, L.P. | 2,109,154 | $24,381,820 | 1.52% |
| Logos Global Management LP | 1,100,000 | $12,716,000 | 1.49% |